4.33
Radiopharm Theranostics Ltd Adr (RADX) 最新ニュース
Radiopharm Theranostics LimitedSponsored ADR (NASDAQ:RADX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Shattuck Labs (STTK) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Ocugen (OCGN) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Atai Beckley N.V. (ATAI) - The Globe and Mail
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart - TipRanks
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Beyond Air (XAIR) - The Globe and Mail
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Fifth Third Bancorp (NASDAQ:FITB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Hartford Multifactor Emerging Markets ETF (NYSEARCA:ROAM) Short Interest Up 110.6% in January - Defense World
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Sees Significant Increase in Short Interest - Defense World
Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Expands By 112.1% - Defense World
GeoVax Labs Inc. (NASDAQ:GOVX) Short Interest Update - Defense World
iShares Environmentally Aware Real Estate ETF (NASDAQ:ERET) Sees Significant Increase in Short Interest - Defense World
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX) - The Globe and Mail
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX) and Resmed (RMD) - The Globe and Mail
Radiopharm Theranostics (ASX:RAD) Prepares for Multiple 2026 Readouts with Firm Cash Position - Kalkine Media
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates - GlobeNewswire Inc.
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates - Sahm
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Radiopharm Theranostics (NASDAQ:RADX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Radiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic - TipRanks
RAD Increases Ownership in Radiopharm Ventures to 87.5% - Sahm
RADX: Interim Readout Achieves 92% Concordance - Research Tree
Equities Analysts Issue Forecasts for RADX FY2026 Earnings - Defense World
RADX FY2026 EPS Reduced by Brookline Capital Management - MarketBeat
Analysts’ Top Healthcare Picks: Foghorn Therapeutics (FHTX), Eton Pharmaceuticals (ETON) - The Globe and Mail
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com India
Radiopharm Theranostics (NASDAQ:RADX) Receives Buy Rating from B. Riley - Defense World
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com UK
Radiopharm Theranostics (NASDAQ:RADX) Earns "Buy" Rating from B. Riley - MarketBeat
Dow Falls 50 Points; US Adds 64,000 Jobs In November - Benzinga
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Benzinga
US stock market crash today: Dow, S&P 500, Nasdaq slide deep into the red — why is the stock market down today? - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.09% - Investing.com India
Radiopharm (RADX) Sees Slight Pessimism From Analysts - Finviz
US stock market crash today: Dow, S&P 500, Nasdaq slide deep into the red — why is the stock market down t - The Economic Times
Radiopharm Theranostics interim data shows 92% reach endpoint in RAD101 study - Investing.com Canada
Radiopharm Theranostics stock soars after positive brain metastases trial data - Investing.com
Radiopharm Theranostics stock soars after positive brain metastases trial data By Investing.com - Investing.com India
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases - Sahm
Book value per share of Radiopharm Theranostics Limited Sponsored ADR – NASDAQ:RADX - TradingView — Track All Markets
Analysts Conflicted on These Healthcare Names: MBX Biosciences, Inc. (MBX), Praxis Precision Medicines (PRAX) and Iovance Biotherapeutics (IOVA) - The Globe and Mail
Radiopharm Theranostics Announces Successful General Meeting Resolutions - TipRanks
Radiopharm Theranostics announces successful general meeting resolutions - MSN
大文字化:
|
ボリューム (24 時間):